Chandra Bhagat Pharma Ltd. Stock Analysis 542934.BO

Chandra Bhagat Pharma Ltd. engages in the business of marketing pharmaceutical, critical care, & health care products. The company is headquartered in Mumbai, Maharashtra and currently employs 40 full-time employees. The company went IPO on 2020-02-14. The firm is engaged in the business of marketing pharmaceutical critical care and health care products. The firm is focused on marketing pharmaceutical formulations and products in the domestic and international market through its own distribution network and sales under its own brand. The company focuses on Injection - IV (Intravenous) and IM (Intramuscular), tablets and capsules supplied to hospitals and health care centers for critical diseases. The firm also deals in importing and supplying active pharmaceutical ingredients (API) and its intermediates. The firm also has its presence in the therapeutic categories for formulations such as anti-cancer (oncology), antibiotics, anesthesia, hormones, orthopedic, cardiac, cardiovascular, antifungal, antiviral, pediatrics, cardiology, nephrology, and neurology. The company is also engaged in promoting and marketing of API in India.